Citigroup
AVEO

Citigroup’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Citigroup’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,200
Closed -$7K – 7889
2020
Q4 		$7K Hold
1,200
– – ﹤0.01% 7063
2020
Q3 		$7K Hold
1,200
– – ﹤0.01% 6873
2020
Q2 		$6K Sell
1,200
-1,370
-53% -$8.65K ﹤0.01% 7242
2020
Q1 		$9K Sell
2,570
-3,910
-60% -$19.4K ﹤0.01% 7107
2019
Q4 		$40K Buy
6,480
+2,120
+49% +$15.6K ﹤0.01% 6498
2019
Q3 		$37K Sell
4,360
-1,130
-21% -$8.41K ﹤0.01% 6332
2019
Q2 		$37K Buy
5,490
+850
+18% +$7.28K ﹤0.01% 6732
2019
Q1 		$38K Sell
4,640
-2,610
-36% -$26.9K ﹤0.01% 6571
2018
Q4 		$116K Buy
7,250
+4,620
+176% +$102K ﹤0.01% 5528
2018
Q3 		$87K Buy
2,630
+810
+45% +$20.8K ﹤0.01% 6039
2018
Q2 		$41K Sell
1,820
-1,850
-50% -$43.9K ﹤0.01% 6444
2018
Q1 		$106K Buy
3,670
+1,280
+54% +$37.4K ﹤0.01% 5569
2017
Q4 		$67K Buy
+2,390
New +$74.2K ﹤0.01% 5973

Citigroup's AVEO Position: Q1 2023 in Review

Citigroup sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 775 shares — an estimated $11.6K sold.

Citigroup first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $128K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Citigroup reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 775 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11.6K.
  • Citigroup first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
  • Citigroup's AVEO Pharmaceuticals, Inc. position peaked at $128K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.